Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where W. David McFadyen is active.

Publication


Featured researches published by W. David McFadyen.


Rapid Communications in Mass Spectrometry | 1998

GAS PHASE ION-MOLECULE REACTIONS IN A MODIFIED ION TRAP: H/D EXCHANGE OF NON-COVALENT COMPLEXES AND COORDINATIVELY UNSATURATED PLATINUM COMPLEXES

Gavin E. Reid; Richard A. J. O’Hair; Michelle L. Styles; W. David McFadyen; Richard J. Simpson

A commercially available electrospray ionization ion trap mass spectrometer has been modified to carry out gas phase ion–molecule reactions. The ability to study gas phase ion–molecule reactions in conjunction with collision induced dissociation (CID) based methods and the multistage trapping capabilities of the ion trap have been exploited in two ways: (i) gas phase H/D exchange reactions inside the ion trap, coupled with CID tandem mass spectrometry have been used to provide insights into the reactivity of non covalent complexes of amino acids and simple peptides, and (ii) CID prior to performing ion–molecule reactions has been used to synthesize and examine the reactivity of coordinatively unsaturated platinum complexes.


Journal of Inorganic Biochemistry | 2000

DNA targeted platinum complexes: synthesis, cytotoxicity and DNA interactions of cis-dichloroplatinum(II) complexes tethered to phenazine-1-carboxamides

Perrin Lc; Paul D. Prenzler; Carleen Cullinane; Don R. Phillips; William A. Denny; W. David McFadyen

A series of intercalator-tethered platinum(II) complexes PtLCl2 have been prepared, where L are the diamine ligands N-[2-[(aminoethyl)amino]ethyl]-phenazine-1-carboxamide, N-[3-[(2-aminoethyl)amino]propyl]-phenazine-1-carboxamide, N-[4-[(2-aminoethyl)amino]butyl]-phenazine-1-carboxamide and N-[5-[(aminoethyl)amino]pentyl]-phenazine-1-carboxamide. Measurements of the time-course of unwinding of supercoiled pUC19 plasmid DNA by the phenazine complexes PtLCl2 reveal that the presence of the intercalator leads to enhanced rates of DNA platination when compared with the complex Pt(en)Cl2. The platinum(II) complexes where the polymethylene linker chain contains three, four or five carbon atoms are considerably more cytotoxic against murine P388/W than either cisplatin, Pt(en)Cl2, or the metal-free ligands themselves.


Journal of Inorganic Biochemistry | 2001

cis-Dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro

Rodney J. Holmes; Mark J. McKeage; Vincent Murray; William A. Denny; W. David McFadyen

A series of intercalator-tethered platinum(II) complexes PtLCl(2) have been prepared where L are the diamine ligands N-[2-[(aminoethyl)amino]ethyl]-9-aminoacridine-4-carboxamide, N-[3-[(2-aminoethyl)amino]propyl]-9-aminoacridine-4-carboxamide, N-[4-[(2-aminoethyl)amino]butyl]-9-aminoacridine-4-carboxamide and N-[5-[(aminoethyl)amino]pentyl]-9-aminoacridine-4-carboxamide and N-[6-[(aminoethyl)amino]hexyl]-9-aminoacridine-4-carboxamide. The activity of the complexes was assessed in the CH-1, CH-1cisR, 41M, 41McisR and SKOV-3 cell lines. The compounds with the shorter linker chain lengths are generally the most active against these cell lines and are much more toxic than Pt(en)C1(2). For example, for the n=2 compound the IC(50) values are 0.017 microM (CH-1), 1.7 microM (41M), 1.4 microM (SKOV-3) and the resistance ratios are 51 (CH-1cisR) and 1.6 (41McisR). For the untethered analogue Pt(en)C1(2) the IC(50) values are 2.5 microM (CH-1), 2.9 microM (41M), 45 microM (SKOV-3) and the resistance ratios are 2.8 (CH-1cisR) and 4.1 (41McisR). The very large differential in IC(50) values between the CH-1 and CH-1cisR pair of cell lines for the 9-aminoacridine-4-carboxamide tethered platinum complexes indicates that repair of platinum-induced DNA damage may be a major determinant of the activity of these compounds.


Biochimica et Biophysica Acta | 2002

The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells.

Mark D. Temple; Patsy Recabarren; W. David McFadyen; Rodney J. Holmes; William A. Denny; Vincent Murray

As part of an ongoing drug development programme, this paper describes the sequence specificity and time course of DNA adduct formation for a series of novel DNA-targeted analogues of cis-diaminedichloroplatinum(II) (cisplatin) (9-aminoacridine-4-carboxamide Pt complexes) in intact HeLa cells. The sequence specificity of DNA damage caused by cisplatin and analogues in human (HeLa) cells was studied using Taq DNA polymerase and a linear amplification/polymerase stop assay. Primer extension is inhibited by a Pt-DNA adduct, and hence the sites of these lesions can be analysed on DNA sequencing gels. The repetitive alphoid DNA sequence was used as the target DNA in human cells. The 9-aminoacridine-4-carboxamide Pt complexes exhibited a markedly different sequence specificity relative to cisplatin and other analogues. The sequence specificity of the 9-aminoacridine-4-carboxamide Pt complexes is shifted away from a preference for runs of guanines. The 9-aminoacridine-4-carboxamide Pt complexes have an enhanced preference for GA dinucleotides. This is the first occasion that an altered DNA sequence specificity has been demonstrated for a cisplatin analogue in human cells. A time course of DNA damage revealed that the DNA-targeted Pt complexes, consisting of four 9-aminoacridine-4-carboxamide Pt complexes and one acridine-4-carboxamide Pt complex, damaged DNA more rapidly compared to cisplatin and non-targeted analogues. A comparison of the time taken to reach half the maximum relative intensity indicated that the DNA-targeted Pt complexes reacted approximately 4-fold faster than cisplatin and the non-targeted analogues.


Biochimica et Biophysica Acta | 1997

Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues

Vincent Murray; Joanne Whittaker; Mark D. Temple; W. David McFadyen

In this paper the sequence specificity of DNA damage has been determined for 11 cisplatin analogues. A number of the analogues used in this study have been included in clinical trials. A Taq DNA polymerase linear amplification technique was utilised to ascertain the sequence selectivity of cisplatin analogues damage to DNA. The analogues differed in their ability to damage DNA with cisplatin being the most effective DNA damaging agent followed by (in decreasing order): tetraplatin (tetrachloro(1,2-diaminocyclohexane)platinum(IV) (RR isomer)), cis-dichlorobis(isopropylamine)platinum(II), dichloro(1,2-diaminocyclohexane)platinum(II) (SS isomer), dichloro(1,2-diaminocyclohexane)platinum(II) (RR isomer), cis-bis(cyclohexylamine)dichloroplatinum(II), carboplatin, cis-dichlorobis(isopentylamine)platinum(II), and CHIP (cis-dichloro-trans-dihydroxybis(isopropylamine)platinum(IV)). However, the sequence specificity of these analogues was similar in position and relative intensity of damage. We also provide evidence that platinum(IV) complexes can damage DNA without being reduced to platinum(II). It was found that a 10-fold higher concentration of cisplatin was required to damage DNA in Tris-HCl compared to Hepes buffers. In this paper we have detected a characteristic pattern of damage with monofunctional analogues that could be used to determine the mode of binding of a cisplatin analogue with DNA. The monofunctional analogues tested were chloro(diethylenetriamine)platinum(II) and cis-diamminechloro(1-octylamine)platinum(II) as well as transplatin.


Chemico-Biological Interactions | 1998

DNA SEQUENCE SELECTIVITY OF CISPLATIN ANALOGUES IN INTACT HUMAN CELLS

Vincent Murray; Joanne Whittaker; W. David McFadyen

The sequence specificity of ten cisplatin analogues was examined in intact human cells. Six of these compounds have anti-tumour activity. The sequence selectivity was investigated using a Taq DNA polymerase/linear amplification assay on damaged DNA extracted from treated cells. Cisplatin and tetraplatin(IV) produced strong damage and DACH RR(II) and cis-[Pt(II)Cl,2(iPrNH2)2] weak DNA damage in intact HeLa cells. The sequence selectivity of tetraplatin(IV) in intact human cells was very similar to that of cisplatin and favored runs of consecutive purines, especially consecutive guanines. The compounds transplatin, carboplatin, cis-[PtCl(NH3)2(C8H17.NH2)], cis-[PtCl2(iPentNH2)2], cis-[PtCl2(C6H11NH2)2, DACH SS(II) and CHIP(IV) did not significantly damage DNA in cells. It was concluded that the interactions of these cisplatin analogues with DNA in human cells were strongly influenced by their ability to damage purified DNA.


Journal of Inorganic Biochemistry | 1997

Reactions of cisplatin and the cis-diamminediaqua platinum(II) cation with tris and hepes

Paul D. Prenxler; W. David McFadyen

Abstract Reactions of Tris and Hepes with cis-(Pt(NH 3 ) 2 ] 2+ moieties were investigated using primarily 15 N AMR spectroscopy. Reaction of both cis-[Pt(NH 3 ) 2 (OH 2 ) 2 ] 2+ (1) and cis-[Pt(NH 3 ) 2 Cl 2 ] (2) with Tris led to the formation of cis-[Pt(NH 3 ) 2 (N, O-TrisH −1 )] + (5) as the thermo-dynamically preferred product, although metastable intermediates were detected during the course of the reaction with 1. 1 and 2 reacted with Hepes to give cis-[Pt(NH 3 ) 2 (N (1) , N (4) -HepesH −1 )] + (8) as the thermodynamically preferred product with metastable intermediates detected in the reaction with 1. Tris reacted more rapidly than Hepes presumably due to increased steric crowding around the nitrogens in the latter. These results indicate that both buffers must be considered as potential ligands in systems wherever buffered solutions of platinum are required.


Biochimica et Biophysica Acta | 1990

The interaction of substituted and rigidly linked diquinolines with DNA

W. David McFadyen; N. Sotirellis; William A. Denny; Laurence P. G. Wakelin

Viscometric measurements with circular and sonicated rodlike DNA fragments were used to explore whether ring substituents or conformationally restricted linkers promote bifunctional intercalation amongst a series of binuclear 4-aminoquinolines bridged via their 4-amino group. We find that ligands comprising unsubstituted quinolines and piperazine or pyrazole linkages bisintercalate. Quinoline-substituted alkyl-linked dimers intercalate in either a mixed monofunctional-bifunctional mode or bind with only one of their chromophores intercalated depending on the nature of the substituents. Equilibrium dialysis measurements show that the binding affinity for calf thymus DNA of the compounds studied ranges from (1.2-12) . 10(4) M-1 in buffer of ionic strength 0.1. Both co-operative and antico-operative binding isotherms were obtained and there is evidence for a second binding mode for the piperazine-linked diquinoline at saturating binding levels. For this compound the high-affinity association constant decreases with increasing ionic strength, 3.4 cations being released per bound ligand molecule. Partition dialysis measurements with DNAs of differing base composition indicate that the compounds studied are either AT selective or sequence neutral depending on ligand structure. For example, the pyrazole linker imparts a marked specificity for binding to AT-rich DNA, whereas the piperazine linker does not. Kinetic measurements using the surfactant-sequestration method reveal that DNA-diquinoline complexes dissociate very rapidly by complex mechanisms with rate constants greater than 100 s-1 in buffer of ionic strength 0.1.


Australian Journal of Chemistry | 2005

Dipyridophenazine complexes of cobalt(III): DNA photocleavage and photobiology

Alison M. Funston; Carleen Cullinane; Kenneth P. Ghiggino; W. David McFadyen; Stanley S. Stylli; Peter A. Tregloan

The UV-visible spectroscopy and photochemistry of [Co(en)2(DPPZ)](ClO4)3 (DPPZ = dipyrido[3,2-a:2´,3´-c]-phenazine) in the presence of plasmid DNA and the nucleoside 2´-deoxygaunosine have been investigated. Evidence for the intercalation of the complex with DNA and photoinduced DNA strand breakage is found. The structurally related complexes [Co(en)2(DPPN)]Cl3 and [Co(en)2(DPPA)]Cl2, where DPPN = benzo[i]dipyrido[3,2-a:2´,3´-c]phenazine and DPPA = dipyrido[3,2-a:2´,3´-c] phenazine-11-carboxylic acid, have also been synthesized and characterized. In vitro cytotoxicity studies and photocytotoxicity studies of the complexes using the C6 rat glioma cell line are reported and indicate significant increases in toxicity following irradation.


Australian Journal of Chemistry | 2001

Gas-Phase and Condensed-Phase Studies on the Reactivity of the Azido(2,2':6',2''-terpyridine)platinum(II) Cation

Sheena Wee; Martin J. Grannas; W. David McFadyen; Richard A. J. O'Hair

The recent report of the gas-phase loss of nitrogen from [Pt(dien)N3]+ (dien = diethylenetriamine) under collisioninduced dissociation conditions has prompted us to investigate whether the analogous fragmentation of [Pt(tpy)N3]+ (tpy = 2,2′: 6′,2″-terpyridine) occurs in the gaseous and condensed phase as well as in the solid state. While such a process occurs in the gaseous phase, attempts to fragment [Pt(tpy)N3]+ by refluxing it in MeCN yielded the tetrazolato complex [Pt(tpy)(N4CMe)]+, and solid state thermolysis resulted in decomposition. In order to examine the mode of binding of the tetrazole to platinum, the related complex [Pt(tpy)(N4CPh)]BF4 was synthesized via a similar route. X-ray crystallography revealed that the tetrazolate ligand in this complex binds through the N 2 position. In addition, the gas-phase reactivity of these complexes has been investigated using electrosprayionization tandem mass spectrometry (ESI-MS/MS). [Pt(tpy)N3]+ fragments to form [Pt(tpy)N]+, which readily reacts with alcohols, CH3CN and (CH3)2CO, to form adducts. The [Pt(tpy)N+R′OH]+ adduct ions (R′ = CH3, CH3CH2 and (CH3)2CH) fragment to yield [Pt(tpy)N+H2]+ ions with concomitant oxidation of the alcohols.

Collaboration


Dive into the W. David McFadyen's collaboration.

Top Co-Authors

Avatar

Vincent Murray

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sheena Wee

University of Melbourne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge